|
1.
|
N FujinoH KuboT SuzukiIsolation of
alveolar epithelial type II progenitor cells from adult human
lungsLab Invest91363378201110.1038/labinvest.2010.18721079581
|
|
2.
|
EL HerzogAR BrodyTV ColbyR MasonMC
WilliamsKnowns and unknowns of the alveolusProc Am Thorac
Soc5778782200810.1513/pats.200803-028HR18757317
|
|
3.
|
D WangDL HavilandAR BurnsE ZsigmondRA
WetselA pure population of lung alveolar epithelial type II cells
derived from human embryonic stem cellsProc Natl Acad Sci
USA10444494454200710.1073/pnas.070005210417360544
|
|
4.
|
AV AndreevaMA KutuzovTA
Voyno-YasenetskayaRegulation of surfactant secretion in alveolar
type II cellsAm J Physiol Lung Cell Mol
Physiol293L259L271200710.1152/ajplung.00112.200717496061
|
|
5.
|
RJ MasonBiology of alveolar type II
cellsRespirology11SupplS12S15200610.1111/j.1440-1843.2006.00800.x
|
|
6.
|
IP NeuringerSH RandellStem cells and
repair of lung injuriesRespir Res56200410.1186/1465-9921-5-6
|
|
7.
|
D WangJE MoralesDG CalameJL AlcornRA
WetselTransplantation of human embryonic stem cell-derived alveolar
epithelial type II cells abrogates acute lung injury in miceMol
Ther18625634201010.1038/mt.2009.31720087316
|
|
8.
|
D FengS ZhangZ HuF FanF JiangR YinL
XuDynamic investigation of alveolar type II cell function in a
long-term survival model of rat lung ischemia-reperfusion
injuryScand J Clin Lab
Invest70364373201010.3109/00365513.2010.49541520560845
|
|
9.
|
JG ShanesKN MinadeoA MoretM GronerSA
TabaieStatin therapy in heart failure: prognostic effects and
potential mechanismsAm Heart
J154617623200710.1016/j.ahj.2007.05.02017892981
|
|
10.
|
GC MakrisG GeroulakosMC MakrisDP
MikhailidisME FalagasThe pleiotropic effects of statins and omega-3
fatty acids against sepsis: a new perspectiveExpert Opin Investig
Drugs19809814201010.1517/13543784.2010.49083020470189
|
|
11.
|
NR VeillardV BraunersreutherC ArnaudF
BurgerG PelliS SteffensF MachSimvastatin modulates chemokine and
chemokine receptor expression by geranylgeranyl isoprenoid pathway
in human endothelial cells and
macrophagesAtherosclerosis1885158200610.1016/j.atherosclerosis.2005.10.015
|
|
12.
|
A UndasM Celinska-LowenhoffM KaczorJ
MusialNew nonlipid effects of statins and their clinical relevance
in cardiovascular diseaseThromb Haemost9110651077200415175791
|
|
13.
|
BV NaiduSM WoolleyAS FarivarR ThomasC
FragaMS MulliganSimvastatin ameliorates injury in an experimental
model of lung ischemia-reperfusionJ Thorac Cardiovasc
Surg126482489200310.1016/S0022-5223(03)00699-812928648
|
|
14.
|
HC MullerK HellwigS RosseauSimvastatin
attenuates ventilator-induced lung injury in miceCrit
Care14R143201010.1186/cc920920673352
|
|
15.
|
DJ KorR IscimenM YilmazMJ BrownDR BrownO
GajicStatin administration did not influence the progression of
lung injury or associated organ failures in a cohort of patients
with acute lung injuryIntensive Care
Med3510391046200910.1007/s00134-009-1421-8
|
|
16.
|
TR CraigMJ DuffyM ShyamsundarC McDowellCM
O’KaneJS ElbornDF McAuleyA randomized clinical trial of
hydroxymethylglutaryl-coenzyme a reductase inhibition for acute
lung injury (The HARP Study)Am J Respir Crit Care
Med183620626201110.1164/rccm.201003-0423OC20870757
|
|
17.
|
M ShyamsundarT CraigC O’KaneD
McAuleyComment on ‘Statin administration did not influence the
progression of lung injury or associated organ failures in a cohort
of patients with acute lung injury’Intensive Care
Med35149414952009
|
|
18.
|
S TakahashiH NakamuraM SekiReversal of
elastase-induced pulmonary emphysema and promotion of alveolar
epithelial cell proliferation by simvastatin in miceAm J Physiol
Lung Cell Mol
Physiol294L882L890200810.1152/ajplung.00238.200718310229
|
|
19.
|
S WolfrumA DendorferM SchuttSimvastatin
acutely reduces myocardial reperfusion injury in vivo by activating
the phosphatidylinositide 3-kinase/Akt pathwayJ Cardiovasc
Pharmacol44348355200410.1097/01.fjc.0000137162.14735.3015475833
|
|
20.
|
RM BellDM YellonAtorvastatin, administered
at the onset of reperfusion, and independent of lipid lowering,
protects the myocardium by up-regulating a pro-survival pathwayJ Am
Coll Cardiol41508515200310.1016/S0735-1097(02)02816-412575984
|
|
21.
|
AA ZekiL FranziJ LastNJ KenyonSimvastatin
inhibits airway hyperreactivity: implications for the mevalonate
pathway and beyondAm J Respir Crit Care
Med180731740200910.1164/rccm.200901-0018OC19608720
|
|
22.
|
B BussolatiMC DeregibusV FonsatoStatins
prevent oxidized LDL-induced injury of glomerular podocytes by
activating the phosphatidylinositol 3-kinase/AKT-signaling pathwayJ
Am Soc Nephrol1619361947200510.1681/ASN.200408062915843472
|
|
23.
|
H WuD LuH JiangSimvastatin-mediated
upregulation of VEGF and BDNF, activation of the PI3K/Akt pathway,
and increase of neurogenesis are associated with therapeutic
improvement after traumatic brain injuryJ
Neurotrauma25130139200810.1089/neu.2007.036918260796
|
|
24.
|
M EtoT KozaiF CosentinoH JochTF
LüscherStatin prevents tissue factor expression in human
endothelial cells: role of Rho/Rho-kinase and Akt
pathwaysCirculation10517561759200210.1161/01.CIR.0000015465.73933.3B11956113
|
|
25.
|
N TakedaM KondoS ItoY ItoK ShimokataH
KumeRole of RhoA inactivation in reduced cell proliferation of
human airway smooth muscle by simvastatinAm J Respir Cell Mol
Biol35722729200610.1165/rcmb.2006-0034OC16858009
|
|
26.
|
L Taraseviciene-StewartR ScerbaviciusKH
ChoeSimvastatin causes endothelial cell apoptosis and attenuates
severe pulmonary hypertensionAm J Physiol Lung Cell Mol
Physiol291L668L676200610.1152/ajplung.00491.200516698853
|
|
27.
|
M WeisC HeeschenAJ GlassfordJP
CookeStatins have biphasic effects on
angiogenesisCirculation105739745200210.1161/hc0602.10339311839631
|
|
28.
|
JI HanaiN DoroAT SasakiS KobayashiLC
CantleyP SethVP SukhatmeInhibition of lung cancer growth: ATP
citrate lyase knockdown and statin treatment leads to dual blockade
of mitogen-actiated protein kinase (MAPK) and
phosphatidylinositol-3- kinase (PI3K)/AKT pathwaysJ Cell
Physiol22717091720201210.1002/jcp.2289521688263
|
|
29.
|
UK KhanzadaOE PardoC MeierJ DownwardMJ
SecklA ArcaroPotent inhibition of small-cell lung cancer cell
growth by simvastatin reveals selective functions of Ras isoforms
in growth factor
signallingOncogene25877887200610.1038/sj.onc.120911716170339
|
|
30.
|
A HoriguchiM SumitomoJ AsakumaT AsanoT
AsanoM Hayakawa3-Hydroxy-3-methylglutaryl-coenzyme A reductase
inhibitor, fluvastatin, as a novel agent for prophylaxis of renal
cancer metastasisClin Cancer
Res1086488655200410.1158/1078-0432.CCR-04-1568
|
|
31.
|
T SanliC LiuA RashidLovastatin sensitizes
lung cancer cells to ionizing radiation: modulation of molecular
pathways of radioresistance and tumor suppressionJ Thorac
Oncol6439450201110.1097/JTO.0b013e3182049d8b21258249
|
|
32.
|
SA GlynnD O’SullivanAJ EustaceM ClynesN
O’DonovanThe 3-hydroxy-3-methylglutaryl-coenzyme A reductase
inhibitors, simvastatin, lovastatin and mevastatin inhibit
proliferation and invasion of melanoma cellsBMC
Cancer89200810.1186/1471-2407-8-9
|
|
33.
|
M KatsumotoT ShinguR KuwashimaA NakataS
NomuraK ChayamaBiphasic effect of HMG-CoA reductase inhibitor,
pitavastatin, on vascular endothelial cells and angiogenesisCirc
J6915471555200510.1253/circj.69.154716308507
|
|
34.
|
RJ MedinaCL O’NeillAB DevineTA GardinerAW
StittThe pleiotropic effects of simvastatin on retinal
microvascular endothelium has important implications for ischaemic
retinopathiesPLoS One3e2584200810.1371/journal.pone.0002584
|
|
35.
|
LC CantleyThe phosphoinositide 3-kinase
pathwayScience29616551657200210.1126/science.296.5573.165512040186
|
|
36.
|
KA FosterCG OsterMM MayerML AveryKL
AudusCharacterization of the A549 cell line as a type II pulmonary
epithelial cell model for drug metabolismExp Cell
Res243359366199810.1006/excr.1998.41729743595
|
|
37.
|
Y HoshinoT MioS NagaiH MikiI ItoT
IzumiCytotoxic effects of cigarette smoke extract on an alveolar
type II cell-derived cell lineAm J Physiol Lung Cell Mol
Physiol281L509L516200111435227
|
|
38.
|
S KannanH HuangD SeegerAlveolar epithelial
type II cells activate alveolar macrophages and mitigate P.
Aeruginosa infectionPLoS
One4e4891200910.1371/journal.pone.000489119305493
|
|
39.
|
M BhaskaranN KolliputiY WangD GouNR
ChintagariL LiuTrans-differentiation of alveolar epithelial type II
cells to type I cells involves autocrine signaling by transforming
growth factor beta 1 through the Smad pathwayJ Biol
Chem28239683976200710.1074/jbc.M609060200
|
